Related Experiment Video
Updated: Mar 23, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
[Application of disease-specific iPS cells for intractable diseases-from pathomechanisms to drug discovery]
Junya Toguchida1, Kyosuke Hino2, Makoto Ikeya2
1Institute for Frontier Medical Sciences, Kyoto University, Japan.
Abstract:
Genetic diseases affecting bone and cartilage, which are main components of the locomotive system, are extremely diverse. Even if the causative genes are known, detail pathomechanisms are not yet disclosed in most of them and no effective treatments are established. One of such condition is fibrodysplasia ossificance progressive, which is characterized by systemic ectopoic bone formation and caused by mutations of ACVR1/ALK2 gene encoding one of typeⅠBMP receptors. Using patient-derived iPS cells, we have succeeded to recapitulate the disease in vitro and found a unexpected molecular mechanism that Activin-A induced the BMP signal through mutant receptors. This novel finding provides us with a key to discover drugs for this condition.
Insights
Fibrodysplasia ossificans progressive (FOP) is a rare genetic disease. Researchers discovered Activin-A activates BMP signaling via mutant ACVR1/ALK2 receptors, revealing a new therapeutic target for FOP.
Area of Science:
- Genetics
- Molecular Biology
- Biochemistry
Context:
- Genetic disorders of the musculoskeletal system, including bone and cartilage, are highly diverse.
- Pathomechanisms and effective treatments for many genetic bone diseases remain elusive.
- Fibrodysplasia ossificans progressive (FOP) is characterized by progressive heterotopic ossification, caused by ACVR1/ALK2 gene mutations.
Purpose:
- To investigate the molecular mechanisms underlying fibrodysplasia ossificans progressive (FOP).
- To utilize patient-derived induced pluripotent stem cells (iPSCs) to model FOP in vitro.
- To identify novel therapeutic targets for FOP.
Summary:
- Patient-derived iPS cells successfully recapitulated FOP in vitro.
- A novel molecular mechanism revealed that Activin-A induces Bone Morphogenetic Protein (BMP) signaling through mutant ACVR1/ALK2 receptors.
- This finding elucidates a key pathway in FOP pathogenesis.
Impact:
- Provides a critical molecular insight into FOP development.
- Identifies a potential therapeutic strategy targeting the Activin-A/BMP signaling pathway.
- Offers a new avenue for drug discovery for fibrodysplasia ossificans progressive.
More Related Videos
08:00Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
Published on: May 14, 2015
11:42In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
Published on: June 10, 2021
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
iPS Cell Differentiation
Stem Cell Culture